Malter Michael, Neuneier Janina, Triller Annika, Kallweit Ulf
Universität Köln, Klinik und Poliklinik für Neurologie.
Zentrum für Narkolepsie/Hypersomnien, Klin. Schlaf- und Neuroimmunologie, Institut für Immunologie, Universität Witten/Herdecke.
Fortschr Neurol Psychiatr. 2021 Mar;89(3):103-113. doi: 10.1055/a-1244-2612. Epub 2020 Dec 18.
Narcolepsy is a hypersomnolence disorder of central origin that presents with a disturbance of the wake-sleep regulation. Lead symptoms consist of excessive daytime sleepiness and cataplexy. Nowadays, two types of narcolepsy are distinguished. Type 1 narcolepsy, formerly known as narcolepsy with cataplexy, is based on hypocretin deficiency. The cause of type 2 narcolepsy, formerly known as narcolepsy without cataplexy, remains mainly unknown. A multimodal approach is necessary for diagnosis. The mean latency between the onset of disease and diagnosis in Europe ranges 14 years. Narcolepsy has a major impact on workability and quality of life. The management of narcolepsy is usually life-long and includes non-pharmacological approaches and a symptomatic pharmacological treatment.
发作性睡病是一种源于中枢的过度嗜睡障碍,表现为觉醒 - 睡眠调节紊乱。主要症状包括日间过度嗜睡和猝倒。如今,发作性睡病分为两种类型。1型发作性睡病,以前称为伴猝倒的发作性睡病,基于下丘脑分泌素缺乏。2型发作性睡病,以前称为不伴猝倒的发作性睡病,其病因主要仍不明。诊断需要采用多模式方法。在欧洲,从疾病发作到诊断的平均间隔时间为14年。发作性睡病对工作能力和生活质量有重大影响。发作性睡病的管理通常是终身的,包括非药物治疗方法和对症药物治疗。